Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market today that its third quarter revenues were up 13 percent year over year to $27.0 million from $23.9 million in Q3 2016.

In a preliminary report last month, the company estimated that it would end up with between $25.9 million and $26.9 million in total revenues for the third quarter of 2017, including product and service revenue of approximately $16.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.